创新药这次不一样

乔令投研
Aug 11, 2025

5亿美元首付款,里程碑潜在总金额120亿美元,恒瑞与GSk最新达成交易将旗下HRS9821PDE3/4除中国区以外的全球权益以及最多11个临床前项目的选择权授权给英国的GSK。本次交易后,恒瑞医药年内的BD收入就已经达到了7.16亿美元,整体可能确认在25财年报表的BD收入达到9亿美元。7月30日,石药集团再次公告与Madrigal就口服GLP-1受体激动剂达成授权协议,同意授权Madrigal在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10